Reports

Industry Research Reports

description

Part 1

description

Part 2

description

Part 3

description

Part 4

description

Part 5

Home > Reports > Medical Devices & Consumables > Global Cell-free Tumor DNA Detection Market Research Report 2025

Global Cell-free Tumor DNA Detection Market Research Report 2025

Global Cell-free Tumor DNA Detection Market Research Report 2025

Industry: Medical Devices & Consumables

Published: 2025-01-13

Pages: 90 Pages

Report ld: 3492695

application for samples

Request Sample

Custom reports

Pre-Order Enquiry

  • Description selected
  • Table of Contents selected
  • Table of Figures selected
  • Related Reports selected
  • PDFPDF Downloadselected
  • Description selected
  • Table of Contents selected
  • Table of Figures selected
  • Related Reports selected
  • PDFPDF Downloadselected

Description

The global market for Cell-free Tumor DNA Detection was valued at US$ 6051 million in the year 2024 and is projected to reach a revised size of US$ 10630 million by 2031, growing at a CAGR of 8.5% during the forecast period.

Cell-free tumor DNA (circulating tumor DNA, ctDNA) testing, the so-called "liquid biopsy". ctDNA refers to the DNA released by tumor cells into the blood circulatory system, which contains information on tumor-derived mutations and gene variations. ctDNA is a tumor marker with broad application prospects, high sensitivity and high specificity, and is suitable for a variety of tumors, providing an opportunity for non-invasive sampling of tumors.

Cell-free Tumor DNA Detection Market Size(US$)

M= millions and B=billions

QYRLogo
North American market for Cell-free Tumor DNA Detection is estimated to increase from $ million in 2024 to reach $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.

Asia-Pacific market for Cell-free Tumor DNA Detection is estimated to increase from $ million in 2024 to reach $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.

The global market for Cell-free Tumor DNA Detection in Breast Cancer is estimated to increase from $ million in 2024 to $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.

The major global companies of Cell-free Tumor DNA Detection include Biocept Inc., Bio-Rad Laboratories Inc., Fluxion Biosciences Inc., F. Hoffmann-La Roche AG, Sysmex Europe SE, Qiagen, NeoGenomics Laboratories Inc., Menarini Silicon Biosystems, Illumina Inc., Guardant Health Inc., etc. In 2024, the world's top three vendors accounted for approximately % of the revenue.

This report aims to provide a comprehensive presentation of the global market for Cell-free Tumor DNA Detection, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Cell-free Tumor DNA Detection.

The Cell-free Tumor DNA Detection market size, estimations, and forecasts are provided in terms of and revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. This report segments the global Cell-free Tumor DNA Detection market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.

For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.

The report will help the Cell-free Tumor DNA Detection companies, new entrants, and industry chain related companies in this market with information on the revenues for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.

Market Segmentation

  • Report Metric

  • Details

  • Report Title

  • Global Cell-free Tumor DNA Detection Market Research Report 2025

  • Forecasted Market Size in 2031

  • US$ 10630 million

  • CAGR(2025-2031)

  • 8.5%

  • Market Size Available for Years

  • 2025-2031

  • Global Cell-free Tumor DNA Detection Companies Covered

  • Biocept Inc.

    Bio-Rad Laboratories Inc.

    Fluxion Biosciences Inc.

    F. Hoffmann-La Roche AG

    Sysmex Europe SE

    Qiagen

    NeoGenomics Laboratories Inc.

    Menarini Silicon Biosystems

    Illumina Inc.

    Guardant Health Inc.

    Shanghai Biotecan Medical Diagnostics Co.,Ltd.

  • Global Cell-free Tumor DNA Detection Market, by Region

  • North America (U.S., Canada, Mexico)

    Europe (Germany, France, UK, Italy, etc.)

    Asia Pacific (China, Japan, South Korea, Southeast Asia, India, etc.)

    South America (Brazil, etc.)

    Middle East and Africa (Turkey, GCC Countries, Africa, etc.)

  • Global Cell-free Tumor DNA Detection Market, Segment by Type

  • Droplet Digital Polymerase Chain Reaction

    Tagged-Amplicon Deep Sequencing

    Others

  • Global Cell-free Tumor DNA Detection Market, Segment by Application

  • Breast Cancer

    Stomach Cancer

    Liver Cancer

    Other

  • Forecast Units

  • Million USD

  • Report Coverage

  • Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Cell-free Tumor DNA Detection company competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 12: The main points and conclusions of the report.

Table of Contents

1 Report Overview
    1.1 Study Scope
    1.2 Market Analysis by Type
        1.2.1 Global Cell-free Tumor DNA Detection Market Size Growth Rate by Type: 2020 VS 2024 VS 2031
        1.2.2 Droplet Digital Polymerase Chain Reaction
        1.2.3 Tagged-Amplicon Deep Sequencing
        1.2.4 Others
    1.3 Market by Application
        1.3.1 Global Cell-free Tumor DNA Detection Market Growth by Application: 2020 VS 2024 VS 2031
        1.3.2 Breast Cancer
        1.3.3 Stomach Cancer
        1.3.4 Liver Cancer
        1.3.5 Other
    1.4 Assumptions and Limitations
    1.5 Study Objectives
    1.6 Years Considered
2 Global Growth Trends
    2.1 Global Cell-free Tumor DNA Detection Market Perspective (2020-2031)
    2.2 Global Cell-free Tumor DNA Detection Growth Trends by Region
        2.2.1 Global Cell-free Tumor DNA Detection Market Size by Region: 2020 VS 2024 VS 2031
        2.2.2 Cell-free Tumor DNA Detection Historic Market Size by Region (2020-2025)
        2.2.3 Cell-free Tumor DNA Detection Forecasted Market Size by Region (2026-2031)
    2.3 Cell-free Tumor DNA Detection Market Dynamics
        2.3.1 Cell-free Tumor DNA Detection Industry Trends
        2.3.2 Cell-free Tumor DNA Detection Market Drivers
        2.3.3 Cell-free Tumor DNA Detection Market Challenges
        2.3.4 Cell-free Tumor DNA Detection Market Restraints
3 Competition Landscape by Key Players
    3.1 Global Top Cell-free Tumor DNA Detection Players by Revenue
        3.1.1 Global Top Cell-free Tumor DNA Detection Players by Revenue (2020-2025)
        3.1.2 Global Cell-free Tumor DNA Detection Revenue Market Share by Players (2020-2025)
    3.2 Global Cell-free Tumor DNA Detection Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
    3.3 Global Key Players Ranking by Cell-free Tumor DNA Detection Revenue
    3.4 Global Cell-free Tumor DNA Detection Market Concentration Ratio
        3.4.1 Global Cell-free Tumor DNA Detection Market Concentration Ratio (CR5 and HHI)
        3.4.2 Global Top 10 and Top 5 Companies by Cell-free Tumor DNA Detection Revenue in 2024
    3.5 Global Key Players of Cell-free Tumor DNA Detection Head office and Area Served
    3.6 Global Key Players of Cell-free Tumor DNA Detection, Product and Application
    3.7 Global Key Players of Cell-free Tumor DNA Detection, Date of Enter into This Industry
    3.8 Mergers & Acquisitions, Expansion Plans
4 Cell-free Tumor DNA Detection Breakdown Data by Type
    4.1 Global Cell-free Tumor DNA Detection Historic Market Size by Type (2020-2025)
    4.2 Global Cell-free Tumor DNA Detection Forecasted Market Size by Type (2026-2031)
5 Cell-free Tumor DNA Detection Breakdown Data by Application
    5.1 Global Cell-free Tumor DNA Detection Historic Market Size by Application (2020-2025)
    5.2 Global Cell-free Tumor DNA Detection Forecasted Market Size by Application (2026-2031)
6 North America
    6.1 North America Cell-free Tumor DNA Detection Market Size (2020-2031)
    6.2 North America Cell-free Tumor DNA Detection Market Growth Rate by Country: 2020 VS 2024 VS 2031
    6.3 North America Cell-free Tumor DNA Detection Market Size by Country (2020-2025)
    6.4 North America Cell-free Tumor DNA Detection Market Size by Country (2026-2031)
    6.5 United States
    6.6 Canada
7 Europe
    7.1 Europe Cell-free Tumor DNA Detection Market Size (2020-2031)
    7.2 Europe Cell-free Tumor DNA Detection Market Growth Rate by Country: 2020 VS 2024 VS 2031
    7.3 Europe Cell-free Tumor DNA Detection Market Size by Country (2020-2025)
    7.4 Europe Cell-free Tumor DNA Detection Market Size by Country (2026-2031)
    7.5 Germany
    7.6 France
    7.7 U.K.
    7.8 Italy
    7.9 Russia
    7.10 Nordic Countries
8 Asia-Pacific
    8.1 Asia-Pacific Cell-free Tumor DNA Detection Market Size (2020-2031)
    8.2 Asia-Pacific Cell-free Tumor DNA Detection Market Growth Rate by Region: 2020 VS 2024 VS 2031
    8.3 Asia-Pacific Cell-free Tumor DNA Detection Market Size by Region (2020-2025)
    8.4 Asia-Pacific Cell-free Tumor DNA Detection Market Size by Region (2026-2031)
    8.5 China
    8.6 Japan
    8.7 South Korea
    8.8 Southeast Asia
    8.9 India
    8.10 Australia
9 Latin America
    9.1 Latin America Cell-free Tumor DNA Detection Market Size (2020-2031)
    9.2 Latin America Cell-free Tumor DNA Detection Market Growth Rate by Country: 2020 VS 2024 VS 2031
    9.3 Latin America Cell-free Tumor DNA Detection Market Size by Country (2020-2025)
    9.4 Latin America Cell-free Tumor DNA Detection Market Size by Country (2026-2031)
    9.5 Mexico
    9.6 Brazil
10 Middle East & Africa
    10.1 Middle East & Africa Cell-free Tumor DNA Detection Market Size (2020-2031)
    10.2 Middle East & Africa Cell-free Tumor DNA Detection Market Growth Rate by Country: 2020 VS 2024 VS 2031
    10.3 Middle East & Africa Cell-free Tumor DNA Detection Market Size by Country (2020-2025)
    10.4 Middle East & Africa Cell-free Tumor DNA Detection Market Size by Country (2026-2031)
    10.5 Turkey
    10.6 Saudi Arabia
    10.7 UAE
11 Key Players Profiles
    11.1 Biocept Inc.
        11.1.1 Biocept Inc. Company Details
        11.1.2 Biocept Inc. Business Overview
        11.1.3 Biocept Inc. Cell-free Tumor DNA Detection Introduction
        11.1.4 Biocept Inc. Revenue in Cell-free Tumor DNA Detection Business (2020-2025)
        11.1.5 Biocept Inc. Recent Development
    11.2 Bio-Rad Laboratories Inc.
        11.2.1 Bio-Rad Laboratories Inc. Company Details
        11.2.2 Bio-Rad Laboratories Inc. Business Overview
        11.2.3 Bio-Rad Laboratories Inc. Cell-free Tumor DNA Detection Introduction
        11.2.4 Bio-Rad Laboratories Inc. Revenue in Cell-free Tumor DNA Detection Business (2020-2025)
        11.2.5 Bio-Rad Laboratories Inc. Recent Development
    11.3 Fluxion Biosciences Inc.
        11.3.1 Fluxion Biosciences Inc. Company Details
        11.3.2 Fluxion Biosciences Inc. Business Overview
        11.3.3 Fluxion Biosciences Inc. Cell-free Tumor DNA Detection Introduction
        11.3.4 Fluxion Biosciences Inc. Revenue in Cell-free Tumor DNA Detection Business (2020-2025)
        11.3.5 Fluxion Biosciences Inc. Recent Development
    11.4 F. Hoffmann-La Roche AG
        11.4.1 F. Hoffmann-La Roche AG Company Details
        11.4.2 F. Hoffmann-La Roche AG Business Overview
        11.4.3 F. Hoffmann-La Roche AG Cell-free Tumor DNA Detection Introduction
        11.4.4 F. Hoffmann-La Roche AG Revenue in Cell-free Tumor DNA Detection Business (2020-2025)
        11.4.5 F. Hoffmann-La Roche AG Recent Development
    11.5 Sysmex Europe SE
        11.5.1 Sysmex Europe SE Company Details
        11.5.2 Sysmex Europe SE Business Overview
        11.5.3 Sysmex Europe SE Cell-free Tumor DNA Detection Introduction
        11.5.4 Sysmex Europe SE Revenue in Cell-free Tumor DNA Detection Business (2020-2025)
        11.5.5 Sysmex Europe SE Recent Development
    11.6 Qiagen
        11.6.1 Qiagen Company Details
        11.6.2 Qiagen Business Overview
        11.6.3 Qiagen Cell-free Tumor DNA Detection Introduction
        11.6.4 Qiagen Revenue in Cell-free Tumor DNA Detection Business (2020-2025)
        11.6.5 Qiagen Recent Development
    11.7 NeoGenomics Laboratories Inc.
        11.7.1 NeoGenomics Laboratories Inc. Company Details
        11.7.2 NeoGenomics Laboratories Inc. Business Overview
        11.7.3 NeoGenomics Laboratories Inc. Cell-free Tumor DNA Detection Introduction
        11.7.4 NeoGenomics Laboratories Inc. Revenue in Cell-free Tumor DNA Detection Business (2020-2025)
        11.7.5 NeoGenomics Laboratories Inc. Recent Development
    11.8 Menarini Silicon Biosystems
        11.8.1 Menarini Silicon Biosystems Company Details
        11.8.2 Menarini Silicon Biosystems Business Overview
        11.8.3 Menarini Silicon Biosystems Cell-free Tumor DNA Detection Introduction
        11.8.4 Menarini Silicon Biosystems Revenue in Cell-free Tumor DNA Detection Business (2020-2025)
        11.8.5 Menarini Silicon Biosystems Recent Development
    11.9 Illumina Inc.
        11.9.1 Illumina Inc. Company Details
        11.9.2 Illumina Inc. Business Overview
        11.9.3 Illumina Inc. Cell-free Tumor DNA Detection Introduction
        11.9.4 Illumina Inc. Revenue in Cell-free Tumor DNA Detection Business (2020-2025)
        11.9.5 Illumina Inc. Recent Development
    11.10 Guardant Health Inc.
        11.10.1 Guardant Health Inc. Company Details
        11.10.2 Guardant Health Inc. Business Overview
        11.10.3 Guardant Health Inc. Cell-free Tumor DNA Detection Introduction
        11.10.4 Guardant Health Inc. Revenue in Cell-free Tumor DNA Detection Business (2020-2025)
        11.10.5 Guardant Health Inc. Recent Development
    11.11 Shanghai Biotecan Medical Diagnostics Co.,Ltd.
        11.11.1 Shanghai Biotecan Medical Diagnostics Co.,Ltd. Company Details
        11.11.2 Shanghai Biotecan Medical Diagnostics Co.,Ltd. Business Overview
        11.11.3 Shanghai Biotecan Medical Diagnostics Co.,Ltd. Cell-free Tumor DNA Detection Introduction
        11.11.4 Shanghai Biotecan Medical Diagnostics Co.,Ltd. Revenue in Cell-free Tumor DNA Detection Business (2020-2025)
        11.11.5 Shanghai Biotecan Medical Diagnostics Co.,Ltd. Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
    13.1 Research Methodology
        13.1.1 Methodology/Research Approach
            13.1.1.1 Research Programs/Design
            13.1.1.2 Market Size Estimation
            13.1.1.3 Market Breakdown and Data Triangulation
        13.1.2 Data Source
            13.1.2.1 Secondary Sources
            13.1.2.2 Primary Sources
    13.2 Author Details
    13.3 Disclaimer

Table of Figures

List of Tables
 Table 1. Global Cell-free Tumor DNA Detection Market Size Growth Rate by Type (US$ Million): 2020 VS 2024 VS 2031
 Table 2. Key Players of Droplet Digital Polymerase Chain Reaction
 Table 3. Key Players of Tagged-Amplicon Deep Sequencing
 Table 4. Key Players of Others
 Table 5. Global Cell-free Tumor DNA Detection Market Size Growth by Application (US$ Million): 2020 VS 2024 VS 2031
 Table 6. Global Cell-free Tumor DNA Detection Market Size by Region (US$ Million): 2020 VS 2024 VS 2031
 Table 7. Global Cell-free Tumor DNA Detection Market Size by Region (2020-2025) & (US$ Million)
 Table 8. Global Cell-free Tumor DNA Detection Market Share by Region (2020-2025)
 Table 9. Global Cell-free Tumor DNA Detection Forecasted Market Size by Region (2026-2031) & (US$ Million)
 Table 10. Global Cell-free Tumor DNA Detection Market Share by Region (2026-2031)
 Table 11. Cell-free Tumor DNA Detection Market Trends
 Table 12. Cell-free Tumor DNA Detection Market Drivers
 Table 13. Cell-free Tumor DNA Detection Market Challenges
 Table 14. Cell-free Tumor DNA Detection Market Restraints
 Table 15. Global Cell-free Tumor DNA Detection Revenue by Players (2020-2025) & (US$ Million)
 Table 16. Global Cell-free Tumor DNA Detection Market Share by Players (2020-2025)
 Table 17. Global Top Cell-free Tumor DNA Detection Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Cell-free Tumor DNA Detection as of 2024)
 Table 18. Ranking of Global Top Cell-free Tumor DNA Detection Companies by Revenue (US$ Million) in 2024
 Table 19. Global 5 Largest Players Market Share by Cell-free Tumor DNA Detection Revenue (CR5 and HHI) & (2020-2025)
 Table 20. Global Key Players of Cell-free Tumor DNA Detection, Headquarters and Area Served
 Table 21. Global Key Players of Cell-free Tumor DNA Detection, Product and Application
 Table 22. Global Key Players of Cell-free Tumor DNA Detection, Date of Enter into This Industry
 Table 23. Mergers & Acquisitions, Expansion Plans
 Table 24. Global Cell-free Tumor DNA Detection Market Size by Type (2020-2025) & (US$ Million)
 Table 25. Global Cell-free Tumor DNA Detection Revenue Market Share by Type (2020-2025)
 Table 26. Global Cell-free Tumor DNA Detection Forecasted Market Size by Type (2026-2031) & (US$ Million)
 Table 27. Global Cell-free Tumor DNA Detection Revenue Market Share by Type (2026-2031)
 Table 28. Global Cell-free Tumor DNA Detection Market Size by Application (2020-2025) & (US$ Million)
 Table 29. Global Cell-free Tumor DNA Detection Revenue Market Share by Application (2020-2025)
 Table 30. Global Cell-free Tumor DNA Detection Forecasted Market Size by Application (2026-2031) & (US$ Million)
 Table 31. Global Cell-free Tumor DNA Detection Revenue Market Share by Application (2026-2031)
 Table 32. North America Cell-free Tumor DNA Detection Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
 Table 33. North America Cell-free Tumor DNA Detection Market Size by Country (2020-2025) & (US$ Million)
 Table 34. North America Cell-free Tumor DNA Detection Market Size by Country (2026-2031) & (US$ Million)
 Table 35. Europe Cell-free Tumor DNA Detection Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
 Table 36. Europe Cell-free Tumor DNA Detection Market Size by Country (2020-2025) & (US$ Million)
 Table 37. Europe Cell-free Tumor DNA Detection Market Size by Country (2026-2031) & (US$ Million)
 Table 38. Asia-Pacific Cell-free Tumor DNA Detection Market Size Growth Rate by Region (US$ Million): 2020 VS 2024 VS 2031
 Table 39. Asia-Pacific Cell-free Tumor DNA Detection Market Size by Region (2020-2025) & (US$ Million)
 Table 40. Asia-Pacific Cell-free Tumor DNA Detection Market Size by Region (2026-2031) & (US$ Million)
 Table 41. Latin America Cell-free Tumor DNA Detection Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
 Table 42. Latin America Cell-free Tumor DNA Detection Market Size by Country (2020-2025) & (US$ Million)
 Table 43. Latin America Cell-free Tumor DNA Detection Market Size by Country (2026-2031) & (US$ Million)
 Table 44. Middle East & Africa Cell-free Tumor DNA Detection Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
 Table 45. Middle East & Africa Cell-free Tumor DNA Detection Market Size by Country (2020-2025) & (US$ Million)
 Table 46. Middle East & Africa Cell-free Tumor DNA Detection Market Size by Country (2026-2031) & (US$ Million)
 Table 47. Biocept Inc. Company Details
 Table 48. Biocept Inc. Business Overview
 Table 49. Biocept Inc. Cell-free Tumor DNA Detection Product
 Table 50. Biocept Inc. Revenue in Cell-free Tumor DNA Detection Business (2020-2025) & (US$ Million)
 Table 51. Biocept Inc. Recent Development
 Table 52. Bio-Rad Laboratories Inc. Company Details
 Table 53. Bio-Rad Laboratories Inc. Business Overview
 Table 54. Bio-Rad Laboratories Inc. Cell-free Tumor DNA Detection Product
 Table 55. Bio-Rad Laboratories Inc. Revenue in Cell-free Tumor DNA Detection Business (2020-2025) & (US$ Million)
 Table 56. Bio-Rad Laboratories Inc. Recent Development
 Table 57. Fluxion Biosciences Inc. Company Details
 Table 58. Fluxion Biosciences Inc. Business Overview
 Table 59. Fluxion Biosciences Inc. Cell-free Tumor DNA Detection Product
 Table 60. Fluxion Biosciences Inc. Revenue in Cell-free Tumor DNA Detection Business (2020-2025) & (US$ Million)
 Table 61. Fluxion Biosciences Inc. Recent Development
 Table 62. F. Hoffmann-La Roche AG Company Details
 Table 63. F. Hoffmann-La Roche AG Business Overview
 Table 64. F. Hoffmann-La Roche AG Cell-free Tumor DNA Detection Product
 Table 65. F. Hoffmann-La Roche AG Revenue in Cell-free Tumor DNA Detection Business (2020-2025) & (US$ Million)
 Table 66. F. Hoffmann-La Roche AG Recent Development
 Table 67. Sysmex Europe SE Company Details
 Table 68. Sysmex Europe SE Business Overview
 Table 69. Sysmex Europe SE Cell-free Tumor DNA Detection Product
 Table 70. Sysmex Europe SE Revenue in Cell-free Tumor DNA Detection Business (2020-2025) & (US$ Million)
 Table 71. Sysmex Europe SE Recent Development
 Table 72. Qiagen Company Details
 Table 73. Qiagen Business Overview
 Table 74. Qiagen Cell-free Tumor DNA Detection Product
 Table 75. Qiagen Revenue in Cell-free Tumor DNA Detection Business (2020-2025) & (US$ Million)
 Table 76. Qiagen Recent Development
 Table 77. NeoGenomics Laboratories Inc. Company Details
 Table 78. NeoGenomics Laboratories Inc. Business Overview
 Table 79. NeoGenomics Laboratories Inc. Cell-free Tumor DNA Detection Product
 Table 80. NeoGenomics Laboratories Inc. Revenue in Cell-free Tumor DNA Detection Business (2020-2025) & (US$ Million)
 Table 81. NeoGenomics Laboratories Inc. Recent Development
 Table 82. Menarini Silicon Biosystems Company Details
 Table 83. Menarini Silicon Biosystems Business Overview
 Table 84. Menarini Silicon Biosystems Cell-free Tumor DNA Detection Product
 Table 85. Menarini Silicon Biosystems Revenue in Cell-free Tumor DNA Detection Business (2020-2025) & (US$ Million)
 Table 86. Menarini Silicon Biosystems Recent Development
 Table 87. Illumina Inc. Company Details
 Table 88. Illumina Inc. Business Overview
 Table 89. Illumina Inc. Cell-free Tumor DNA Detection Product
 Table 90. Illumina Inc. Revenue in Cell-free Tumor DNA Detection Business (2020-2025) & (US$ Million)
 Table 91. Illumina Inc. Recent Development
 Table 92. Guardant Health Inc. Company Details
 Table 93. Guardant Health Inc. Business Overview
 Table 94. Guardant Health Inc. Cell-free Tumor DNA Detection Product
 Table 95. Guardant Health Inc. Revenue in Cell-free Tumor DNA Detection Business (2020-2025) & (US$ Million)
 Table 96. Guardant Health Inc. Recent Development
 Table 97. Shanghai Biotecan Medical Diagnostics Co.,Ltd. Company Details
 Table 98. Shanghai Biotecan Medical Diagnostics Co.,Ltd. Business Overview
 Table 99. Shanghai Biotecan Medical Diagnostics Co.,Ltd. Cell-free Tumor DNA Detection Product
 Table 100. Shanghai Biotecan Medical Diagnostics Co.,Ltd. Revenue in Cell-free Tumor DNA Detection Business (2020-2025) & (US$ Million)
 Table 101. Shanghai Biotecan Medical Diagnostics Co.,Ltd. Recent Development
 Table 102. Research Programs/Design for This Report
 Table 103. Key Data Information from Secondary Sources
 Table 104. Key Data Information from Primary Sources
 Table 105. Authors List of This Report


List of Figures
 Figure 1. Cell-free Tumor DNA Detection Picture
 Figure 2. Global Cell-free Tumor DNA Detection Market Size Comparison by Type (2020-2031) & (US$ Million)
 Figure 3. Global Cell-free Tumor DNA Detection Market Share by Type: 2024 VS 2031
 Figure 4. Droplet Digital Polymerase Chain Reaction Features
 Figure 5. Tagged-Amplicon Deep Sequencing Features
 Figure 6. Others Features
 Figure 7. Global Cell-free Tumor DNA Detection Market Size by Application (2020-2031) & (US$ Million)
 Figure 8. Global Cell-free Tumor DNA Detection Market Share by Application: 2024 VS 2031
 Figure 9. Breast Cancer Case Studies
 Figure 10. Stomach Cancer Case Studies
 Figure 11. Liver Cancer Case Studies
 Figure 12. Other Case Studies
 Figure 13. Cell-free Tumor DNA Detection Report Years Considered
 Figure 14. Global Cell-free Tumor DNA Detection Market Size (US$ Million), Year-over-Year: 2020-2031
 Figure 15. Global Cell-free Tumor DNA Detection Market Size, (US$ Million), 2020 VS 2024 VS 2031
 Figure 16. Global Cell-free Tumor DNA Detection Market Share by Region: 2024 VS 2031
 Figure 17. Global Cell-free Tumor DNA Detection Market Share by Players in 2024
 Figure 18. Global Top Cell-free Tumor DNA Detection Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Cell-free Tumor DNA Detection as of 2024)
 Figure 19. The Top 10 and 5 Players Market Share by Cell-free Tumor DNA Detection Revenue in 2024
 Figure 20. North America Cell-free Tumor DNA Detection Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 21. North America Cell-free Tumor DNA Detection Market Share by Country (2020-2031)
 Figure 22. United States Cell-free Tumor DNA Detection Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 23. Canada Cell-free Tumor DNA Detection Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 24. Europe Cell-free Tumor DNA Detection Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 25. Europe Cell-free Tumor DNA Detection Market Share by Country (2020-2031)
 Figure 26. Germany Cell-free Tumor DNA Detection Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 27. France Cell-free Tumor DNA Detection Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 28. U.K. Cell-free Tumor DNA Detection Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 29. Italy Cell-free Tumor DNA Detection Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 30. Russia Cell-free Tumor DNA Detection Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 31. Nordic Countries Cell-free Tumor DNA Detection Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 32. Asia-Pacific Cell-free Tumor DNA Detection Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 33. Asia-Pacific Cell-free Tumor DNA Detection Market Share by Region (2020-2031)
 Figure 34. China Cell-free Tumor DNA Detection Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 35. Japan Cell-free Tumor DNA Detection Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 36. South Korea Cell-free Tumor DNA Detection Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 37. Southeast Asia Cell-free Tumor DNA Detection Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 38. India Cell-free Tumor DNA Detection Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 39. Australia Cell-free Tumor DNA Detection Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 40. Latin America Cell-free Tumor DNA Detection Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 41. Latin America Cell-free Tumor DNA Detection Market Share by Country (2020-2031)
 Figure 42. Mexico Cell-free Tumor DNA Detection Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 43. Brazil Cell-free Tumor DNA Detection Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 44. Middle East & Africa Cell-free Tumor DNA Detection Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 45. Middle East & Africa Cell-free Tumor DNA Detection Market Share by Country (2020-2031)
 Figure 46. Turkey Cell-free Tumor DNA Detection Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 47. Saudi Arabia Cell-free Tumor DNA Detection Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 48. UAE Cell-free Tumor DNA Detection Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 49. Biocept Inc. Revenue Growth Rate in Cell-free Tumor DNA Detection Business (2020-2025)
 Figure 50. Bio-Rad Laboratories Inc. Revenue Growth Rate in Cell-free Tumor DNA Detection Business (2020-2025)
 Figure 51. Fluxion Biosciences Inc. Revenue Growth Rate in Cell-free Tumor DNA Detection Business (2020-2025)
 Figure 52. F. Hoffmann-La Roche AG Revenue Growth Rate in Cell-free Tumor DNA Detection Business (2020-2025)
 Figure 53. Sysmex Europe SE Revenue Growth Rate in Cell-free Tumor DNA Detection Business (2020-2025)
 Figure 54. Qiagen Revenue Growth Rate in Cell-free Tumor DNA Detection Business (2020-2025)
 Figure 55. NeoGenomics Laboratories Inc. Revenue Growth Rate in Cell-free Tumor DNA Detection Business (2020-2025)
 Figure 56. Menarini Silicon Biosystems Revenue Growth Rate in Cell-free Tumor DNA Detection Business (2020-2025)
 Figure 57. Illumina Inc. Revenue Growth Rate in Cell-free Tumor DNA Detection Business (2020-2025)
 Figure 58. Guardant Health Inc. Revenue Growth Rate in Cell-free Tumor DNA Detection Business (2020-2025)
 Figure 59. Shanghai Biotecan Medical Diagnostics Co.,Ltd. Revenue Growth Rate in Cell-free Tumor DNA Detection Business (2020-2025)
 Figure 60. Bottom-up and Top-down Approaches for This Report
 Figure 61. Data Triangulation
 Figure 62. Key Executives Interviewed

Description 

The global market for Cell-free Tumor DNA Detection was valued at US$ 6051 million in the year 2024 and is projected to reach a revised size of US$ 10630 million by 2031, growing at a CAGR of 8.5% during the forecast period.

Cell-free tumor DNA (circulating tumor DNA, ctDNA) testing, the so-called "liquid biopsy". ctDNA refers to the DNA released by tumor cells into the blood circulatory system, which contains information on tumor-derived mutations and gene variations. ctDNA is a tumor marker with broad application prospects, high sensitivity and high specificity, and is suitable for a variety of tumors, providing an opportunity for non-invasive sampling of tumors.
North American market for Cell-free Tumor DNA Detection is estimated to increase from $ million in 2024 to reach $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.

Asia-Pacific market for Cell-free Tumor DNA Detection is estimated to increase from $ million in 2024 to reach $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.

The global market for Cell-free Tumor DNA Detection in Breast Cancer is estimated to increase from $ million in 2024 to $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.

The major global companies of Cell-free Tumor DNA Detection include Biocept Inc., Bio-Rad Laboratories Inc., Fluxion Biosciences Inc., F. Hoffmann-La Roche AG, Sysmex Europe SE, Qiagen, NeoGenomics Laboratories Inc., Menarini Silicon Biosystems, Illumina Inc., Guardant Health Inc., etc. In 2024, the world's top three vendors accounted for approximately % of the revenue.

This report aims to provide a comprehensive presentation of the global market for Cell-free Tumor DNA Detection, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Cell-free Tumor DNA Detection.

The Cell-free Tumor DNA Detection market size, estimations, and forecasts are provided in terms of and revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. This report segments the global Cell-free Tumor DNA Detection market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.

For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.

The report will help the Cell-free Tumor DNA Detection companies, new entrants, and industry chain related companies in this market with information on the revenues for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.

Market Segmentation
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Cell-free Tumor DNA Detection company competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 12: The main points and conclusions of the report.
den_biaoTiZhungShi

Related Reports

Global Cell-free Tumor DNA Detection Market Research Report 2025

Industry: Medical Devices & Consumables

Published: 2025-01-13

Pages: 90 Pages

Report ld: 3492695

application for samples

Request Sample

Custom reports

Pre-Order Enquiry

CHOOSE LICENSE TYPE
tip

USD 2900.00

tip

USD 4350.00

tip

USD 5800.00

Add to Cart

Add to Cart

Buy Now

Buy Now

Have a question?
SIMON LEE

English

English

SIMON LEE

+1-62 6295 2442

Online

JOHN WANG

English

English

JOHN WANG

+41 765 899 438

Offline

HITESH

English

English

HITESH

+91-86 6998 6909

Offline

TANG XIN

Japanese

Japanese

TANG XIN

+81-90 3800 9273

Offline

SUNG-BIN YOON

Korean

Korean

SUNG-BIN YOON

+82-2883 1278

Offline

YUJIE TIAN

English

English

YUJIE TIAN

+86-135-2215-3954

Offline

DAMON

Chinese

Chinese

DAMON

+86-133 1872 9947

Offline

General Email:
global@qyresearch.com
WHAT QYRESEARCH OFFER?
Competition

Competition

Key players, new entrants,acquisitions, mergers and expansions,development trends and challenges.

Industry Analysis

Industry Analysis

Rawmaterial, application, product type, demand,supply,downstream, supply chain etc.

Market Size

Market Size

Capacity, production, sales, revenue, price, cost etc.

Customized Information

Customized Information

We can offer customized survey and information to meet ourclient's need.

INTEREST IN THIS REPORT?

Get A Free Sample >>
WHY QYR?
  • Fastest report delivery service

    Fastest report delivery service

  • More than 19 years of vast experience

    More than 19 years of vast experience

  • Operation for 24 * 7 & 365 days

    Operation for 24 * 7 & 365 days

  • In-depth and comprehensive analysis

    In-depth and comprehensive analysis

  • Professional and timely after-sales service

    Professional and timely after-sales service

  • Owns large database

    Owns large database

biaoTi

WORLD WIDE OFFICE

application for samples

Request Sample

Custom reports

Pre-Order Enquiry

Add to Cart

Add to Cart

Buy Now

Buy Now